17 trademarks were found for owners matching the name Mallinckrodt Pharmaceuticals Ireland Limited.
#Classstatus
1 S:98439946
M:EVOLVE
O:Mallinckrodt Pharmaceuticals Ireland Limited
5, 10 Pending
2 S:98439982
M:O
O:Mallinckrodt Pharmaceuticals Ireland Limited
5, 10 Pending
3 S:98440102
M:SELFJECT
O:Mallinckrodt Pharmaceuticals Ireland Limited
5 Pending
4 S:97934575
M:INOFLO EVOLVE DS
O:Mallinckrodt Pharmaceuticals Ireland Limited
5, 10 Pending
5 S:97855229
M:EINOCAL
O:Mallinckrodt Pharmaceuticals Ireland Limited
1, 10, 11 Pending
6 S:97820856
M:INOMAX EVOLVE
O:Mallinckrodt Pharmaceuticals Ireland Limited
5, 10 Pending
7 S:97613272
M:4880
O:Mallinckrodt Pharmaceuticals Ireland Limited
5 Pending
8 S:97026259
M:EVOLVE

O:Mallinckrodt Hospital Products IP Unlimited, Mallinckrodt Pharmaceuticals Ireland Limited
10 Pending
9 S:88900093
M:TERLIVAZ TERLIPRESSIN FOR INJECTION

O:Mallinckrodt Hospital Products IP Limited, MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
5 Registered
10 S:79273317
M:BELESALA
O:Mallinckrodt Pharmaceuticals Ireland Limited
5, 10 Registered
11 S:88464881
M:S SONORANT THERAPEUTICS

O:Mallinckrodt Pharmaceuticals Ireland Limited
5, 10, 40, 41, 42 Registered
12 S:88464893
M:S SONORANT THERAPEUTICS

O:Mallinckrodt Pharmaceuticals Ireland Limited
5, 10, 40, 41, 42 Registered
13 S:88464898
M:S

O:Mallinckrodt Pharmaceuticals Ireland Limited
5, 10, 40, 41, 42 Registered
14 S:88464907
M:S

O:Mallinckrodt Pharmaceuticals Ireland Limited
5, 10, 40, 41, 42 Registered
15 S:88459416
M:SONORANT
O:Mallinckrodt Pharmaceuticals Ireland Limited
5, 10, 40, 41, 42 Registered
16 S:79026694
M:INOBLENDER
O:AGA AB, INO Therapeutics LLC, Mallinckrodt Hospital Products IP Limite, Mallinckrodt Pharmaceuticals Ireland Limited
10 Registered
17 S:79026770
M:INOMAX
O:AGA AB, INO Therapeutics LLC, Mallinckrodt Critical Care Finance Inc., Mallinckrodt Hospital Products IP Limited, Mallinckrodt IP, Mallinckrodt Pharma IP Trading D.A.C., Mallinckrodt Pharmaceuticals Ireland Limited, Therakos, Inc.
10 Registered
Trademark Alertz updated from USPTO on 2030-01-24